Russia’s cancer vaccine could receive approval by August, allowing treatment to begin, the head of the Gamaleya Research Institute has said Read...
Vous n'êtes pas connecté
A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology is expected to receive regulatory approval by August, potentially allowing treatments to commence as early as September, according to the institute’s director, Alexander Gintsburg. This breakthrough marks a significant milestone in the global fight against cancer, leveraging advanced mRNA technology […]
Russia’s cancer vaccine could receive approval by August, allowing treatment to begin, the head of the Gamaleya Research Institute has said Read...
Small deviations in the structure of the monkey flower virus can lead to mass transmission of the virus through droplets in the air. This was stated...
By Rafiq Vayani KARACHI: easypaisa has achieved a groundbreaking milestone by becoming Pakistan’s first Digital Retail Bank to receive commercial...
Rift Valley Fever Vaccine : Hope as South African Company Joins Effort By Gift Briton Global efforts for a Rift Valley fever (RVF) vaccine accelerate...
3D models of uveal melanoma are transforming cancer research, enabling personalized treatments and better drug testing for this aggressive eye...
Biohacking is a rapidly growing movement that combines technology, biology, and self-experimentation to optimize human performance and well-being....
Imagine a smartphone that can check for spoiled food, detect counterfeit drugs, or even diagnose diseases. This futuristic vision is becoming a...
Oracle marks a significant milestone by hosting the inaugural CloudWorld […]
Researchers from Tokyo Metropolitan University have developed a new dye that can strongly absorb second near-IR radiation and transform it to heat.
In reply to <a...